ATG101

gene
On this page

Also known as FLJ11773

Summary

ATG101 (autophagy related 101, HGNC:25679) is a protein-coding gene on chromosome 12q13.13, encoding Autophagy-related protein 101 (Q9BSB4). Autophagy factor required for autophagosome formation.

Enables identical protein binding activity. Involved in autophagosome assembly and negative regulation of cell population proliferation. Located in phagophore assembly site. Part of Atg1/ULK1 kinase complex. Biomarker of cholangiocarcinoma; colon cancer; and hepatocellular carcinoma.

Source: NCBI Gene 60673 — RefSeq curated summary.

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 40 total
  • MANE Select transcript: NM_021934

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25679
Approved symbolATG101
Nameautophagy related 101
Location12q13.13
Locus typegene with protein product
StatusApproved
AliasesFLJ11773
Ensembl geneENSG00000123395
Ensembl biotypeprotein_coding
OMIM615089
Entrez60673

Gene structure

Transcript identifiers

Ensembl transcripts: 15 — 12 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000336854, ENST00000547409, ENST00000548915, ENST00000550604, ENST00000552544, ENST00000552947, ENST00000553049, ENST00000908677, ENST00000908678, ENST00000938048, ENST00000938049, ENST00000938050, ENST00000938051, ENST00000938052, ENST00000938053

RefSeq mRNA: 2 — MANE Select: NM_021934 NM_001098673, NM_021934

CCDS: CCDS8820

Canonical transcript exons

ENST00000336854 — 4 exons

ExonStartEnd
ENSE000010607175207035452070483
ENSE000013312495207357552073902
ENSE000013482225207678652077495
ENSE000014234355206997852070242

Expression profiles

Bgee: expression breadth ubiquitous, 278 present calls, max score 96.25.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 22.2122 / max 129.2132, expressed in 1811 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
12557022.07941811
1255710.132812

Top tissues by expression

285 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
stromal cell of endometriumCL:000225596.25gold quality
parotid glandUBERON:000183193.14gold quality
mucosa of transverse colonUBERON:000499192.71gold quality
body of stomachUBERON:000116192.58gold quality
skin of abdomenUBERON:000141691.70gold quality
skin of legUBERON:000151191.61gold quality
gall bladderUBERON:000211091.48gold quality
islet of LangerhansUBERON:000000691.06gold quality
saliva-secreting glandUBERON:000104490.98gold quality
left testisUBERON:000453390.94gold quality
granulocyteCL:000009490.85gold quality
prefrontal cortexUBERON:000045190.77gold quality
right testisUBERON:000453490.69gold quality
minor salivary glandUBERON:000183090.66gold quality
gastrocnemiusUBERON:000138890.56gold quality
zone of skinUBERON:000001490.24gold quality
muscle of legUBERON:000138390.24gold quality
upper lobe of left lungUBERON:000895290.23gold quality
stomachUBERON:000094590.15gold quality
hindlimb stylopod muscleUBERON:000425290.11gold quality
monocyteCL:000057689.96gold quality
ascending aortaUBERON:000149689.95gold quality
testisUBERON:000047389.93gold quality
left uterine tubeUBERON:000130389.91gold quality
adenohypophysisUBERON:000219689.83gold quality
thoracic aortaUBERON:000151589.80gold quality
apex of heartUBERON:000209889.78gold quality
mononuclear cellCL:000084289.73gold quality
mouth mucosaUBERON:000372989.73gold quality
upper lobe of lungUBERON:000894889.69gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-93593yes7.66
E-ANND-3yes6.81
E-CURD-11no99.26

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

20 targeting ATG101, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-453199.9969.703181
HSA-MIR-6744-5P99.9366.82748
HSA-MIR-430699.7270.503630
HSA-MIR-519A-3P99.6771.671868
HSA-MIR-519B-3P99.6771.671868
HSA-MIR-519C-3P99.6771.671870
HSA-MIR-7156-5P99.6468.811369
HSA-MIR-3136-3P99.5766.59781
HSA-MIR-7155-3P99.5766.48794
HSA-MIR-427399.4567.931206
HSA-MIR-318299.4068.152454
HSA-MIR-185-5P99.3568.602497
HSA-MIR-464499.3569.122514
HSA-MIR-520A-5P99.3566.721632
HSA-MIR-525-5P99.3566.851615
HSA-MIR-4685-5P99.2565.991563
HSA-MIR-6827-5P98.4664.881256
HSA-MIR-6511A-3P97.6066.61713
HSA-MIR-6511B-3P97.6066.61713
HSA-MIR-1211594.1966.37738

Literature-anchored findings (GeneRIF, showing 9)

  • The identification of the novel protein, Atg101, and the validation of Atg13 and Atg101 as ULK1-interacting proteins, suggests an Atg1 complex is involved in the induction of macroautophagy in mammalian cells. (PMID:19287211)
  • These data suggest that Atg101 is a novel Atg protein that functions together with ULK, Atg13 and FIP200. (PMID:19597335)
  • Data indicate mitogen lacritin stimulates FOXO3-ATG101 and FOXO1-ATG7 autophagic coupling and restores metabolic homeostasis. (PMID:23640897)
  • Structure of the human Atg13-Atg101 HORMA heterodimer in the ULK1 complex that controls autophagy has been described. (PMID:26299944)
  • The C-terminal deletion of ATG101 shows a significant defect in the interaction with PtdIns3K components and subsequently impairs autophagosome formation. This result clearly presents an additional role of ATG101 for bridging the ULK1 and PtdIns3K complexes in the mammalian autophagy process. (PMID:30081750)
  • ATG101 Degradation by HUWE1-Mediated Ubiquitination Impairs Autophagy and Reduces Survival in Cancer Cells. (PMID:34502089)
  • ATG101-related signature predicts prognosis and therapeutic option in hepatocellular carcinoma. (PMID:36302799)
  • Metamorphosis by ATG13 and ATG101 in human autophagy initiation. (PMID:37394799)
  • The role of the HORMA domain proteins ATG13 and ATG101 in initiating autophagosome biogenesis. (PMID:37567770)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerioatg101ENSDARG00000043287
mus_musculusAtg101ENSMUSG00000037204
rattus_norvegicusAtg101ENSRNOG00000007756
drosophila_melanogasterAtg101FBGN0030960
caenorhabditis_elegansWBGENE00022078

Protein

Protein identifiers

Autophagy-related protein 101Q9BSB4 (reviewed: Q9BSB4)

All UniProt accessions (4): Q9BSB4, F8VQD9, F8VVA0, H3BMZ4

UniProt curated annotations — full annotation on UniProt →

Function. Autophagy factor required for autophagosome formation. Stabilizes ATG13, protecting it from proteasomal degradation.

Subunit / interactions. Interacts with ATG13. Associates with a complex composed of ATG13, ULK1 and RB1CC1; the association with this complex requires the presence of ATG13.

Subcellular location. Cytoplasm. Preautophagosomal structure.

Similarity. Belongs to the ATG101 family.

RefSeq proteins (2): NP_001092143, NP_068753* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR012445ATG101Family

Pfam: PF07855

UniProt features (28 total): strand 13, helix 7, mutagenesis site 5, chain 1, region of interest 1, sequence conflict 1

Structure

Experimental structures (PDB)

8 structures.

PDBMethodResolution (Å)
5C50X-RAY DIFFRACTION1.63
4WZGX-RAY DIFFRACTION1.9
5XUYX-RAY DIFFRACTION2.2
8DO8X-RAY DIFFRACTION2.41
5XV6X-RAY DIFFRACTION2.46
5XV1X-RAY DIFFRACTION2.51
5XV3X-RAY DIFFRACTION2.57
5XV4X-RAY DIFFRACTION2.95

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BSB4-F190.300.81

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Mutagenesis-validated functional residues (5):

PositionPhenotype
31impairs interaction with atg13; when associated with r-54.
54impairs interaction with atg13; when associated with s-31.
152abolishes interaction with atg13; when associated with d-153 and d-156.
153abolishes interaction with atg13; when associated with d-152 and d-156.
156abolishes interaction with atg13; when associated with d-152 and d-152.

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-1632852Macroautophagy
R-HSA-9612973Autophagy

MSigDB gene sets: 163 (showing top): GOBP_REGULATION_OF_AUTOPHAGY, GOBP_VACUOLE_ORGANIZATION, GOBP_LIPOPROTEIN_METABOLIC_PROCESS, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, NAGASHIMA_NRG1_SIGNALING_UP, GOBP_MACROAUTOPHAGY, GOBP_REGULATION_OF_CATABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS, WCTCNATGGY_UNKNOWN, GOBP_LIPOPROTEIN_BIOSYNTHETIC_PROCESS, GOBP_ORGANELLE_ASSEMBLY, GOBP_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY, GOBP_AUTOPHAGOSOME_ORGANIZATION, GOCC_TRANSFERASE_COMPLEX_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS

GO Biological Process (4): autophagosome assembly (GO:0000045), negative regulation of cell population proliferation (GO:0008285), positive regulation of autophagy (GO:0010508), autophagy (GO:0006914)

GO Molecular Function (4): protein kinase binding (GO:0019901), identical protein binding (GO:0042802), protein-containing complex binding (GO:0044877), protein binding (GO:0005515)

GO Cellular Component (5): phagophore assembly site (GO:0000407), endoplasmic reticulum membrane (GO:0005789), cytosol (GO:0005829), Atg1/ULK1 kinase complex (GO:1990316), cytoplasm (GO:0005737)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Autophagy1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cytoplasm3
cellular anatomical structure3
binding2
Atg12 activating enzyme activity1
protein-phosphatidylethanolamide deconjugating activity1
Atg12 conjugating enzyme activity1
Atg12 ligase activity1
organelle assembly1
Atg1/ULK1 kinase complex assembly1
autophagosome organization1
cell population proliferation1
regulation of cell population proliferation1
negative regulation of cellular process1
autophagy1
positive regulation of catabolic process1
regulation of autophagy1
catabolic process1
transmembrane transport1
process utilizing autophagic mechanism1
kinase binding1
protein binding1
organelle membrane1
nuclear outer membrane-endoplasmic reticulum membrane network1
endoplasmic reticulum subcompartment1
serine/threonine protein kinase complex1
intracellular anatomical structure1

Protein interactions and networks

STRING

1186 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ATG101RB1CC1Q8TDY2998
ATG101ULK1O75385998
ATG101ATG13O75143998
ATG101ULK2Q8IYT8997
ATG101CIB1Q99828922
ATG101ATG5Q9H1Y0897
ATG101ATG14Q6ZNE5892
ATG101WIPI1Q5MNZ9875
ATG101PIK3C3Q8NEB9864
ATG101PIK3R4Q99570863
ATG101ATG12O94817857
ATG101BECN1Q14457845
ATG101ATG16L1Q676U5845
ATG101ATG10Q9H0Y0840
ATG101ATG3Q9NT62839

IntAct

68 interactions, top by confidence:

ABTypeScore
ATG101ATG13psi-mi:“MI:0914”(association)0.950
ATG13ATG101psi-mi:“MI:0915”(physical association)0.950
ATG101ATG13psi-mi:“MI:0915”(physical association)0.950
ATG13ATG101psi-mi:“MI:0407”(direct interaction)0.950
ATG13ULK1psi-mi:“MI:0914”(association)0.940
ULK1ATG13psi-mi:“MI:0914”(association)0.940
ATG13ULK1psi-mi:“MI:2364”(proximity)0.940
RB1CC1ATG101psi-mi:“MI:0915”(physical association)0.860
HUS1RAD1psi-mi:“MI:0914”(association)0.840
RB1CC1ATG13psi-mi:“MI:0914”(association)0.820
MAP1LC3CATG13psi-mi:“MI:0914”(association)0.750
BRK1HSBP1psi-mi:“MI:0914”(association)0.740
MAP1LC3BATG13psi-mi:“MI:0914”(association)0.730
ATG101MAP1LC3Cpsi-mi:“MI:0407”(direct interaction)0.730
ATG101MAP1LC3Cpsi-mi:“MI:0915”(physical association)0.730

BioGRID (236): ATG101 (Affinity Capture-MS), ATG101 (Affinity Capture-MS), ATG101 (Affinity Capture-MS), ATG101 (Affinity Capture-MS), RB1CC1 (Affinity Capture-Western), ATG13 (Affinity Capture-Western), ULK1 (Affinity Capture-Western), ATG101 (Affinity Capture-Western), ATG101 (Affinity Capture-Western), ATG101 (Affinity Capture-Western), ATG101 (Affinity Capture-MS), ATG101 (Affinity Capture-MS), ATG101 (Affinity Capture-MS), ATG101 (Affinity Capture-MS), ATG101 (Affinity Capture-MS)

ESM2 similar proteins: A4IH75, B0S6R1, F4K265, O14417, O75165, O94915, P28660, P60670, P97878, Q10LJ0, Q2HJE0, Q2TBN7, Q3B736, Q3B8G8, Q3TPX4, Q499N2, Q4R6Q7, Q4R708, Q556Y9, Q5E9X5, Q5R6U8, Q5R8B7, Q5RBT3, Q5VZE5, Q5XHA1, Q5ZHV2, Q642Q3, Q6AY69, Q6DE58, Q6DKG0, Q6GLR7, Q6NPF4, Q6P2C8, Q6PFL0, Q6PHQ8, Q6Q7J5, Q7T322, Q8BJ63, Q8TAT6, Q8VDP2

Diamond homologs: A4IH75, Q2HJE0, Q3B736, Q6AY69, Q6DE58, Q9BSB4, Q9D8Z6

SIGNOR signaling

1 interactions.

AEffectBMechanism
ATG101up-regulatesATG13binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 41 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Macroautophagy1147.0×3e-14
Autophagy527.5×5e-05

GO biological processes:

GO termPartnersFoldFDR
mitophagy979.5×2e-13
autophagosome assembly1168.7×1e-15
autophagosome maturation658.5×5e-08
positive regulation of autophagy528.9×3e-05
autophagy618.4×3e-05

Disease & clinical

Clinical variants and AI predictions

ClinVar

40 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance29
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

894 predictions. Top by Δscore:

VariantEffectΔscore
12:52076781:CCCA:Cacceptor_loss1.0000
12:52076783:CAGGA:Cacceptor_loss1.0000
12:52076784:A:ACacceptor_loss1.0000
12:52076784:A:AGacceptor_gain1.0000
12:52076784:AG:Aacceptor_gain1.0000
12:52076784:AGGAT:Aacceptor_gain1.0000
12:52076785:G:GTacceptor_gain1.0000
12:52076785:GG:Gacceptor_gain1.0000
12:52076785:GGA:Gacceptor_gain1.0000
12:52076785:GGAT:Gacceptor_gain1.0000
12:52076785:GGATG:Gacceptor_gain1.0000
12:52070025:A:Tdonor_gain0.9800
12:52070432:G:GTdonor_gain0.9800
12:52073886:T:TAdonor_gain0.9800
12:52073887:T:TAdonor_gain0.9800
12:52073900:AAGG:Adonor_loss0.9800
12:52073901:AG:Adonor_loss0.9800
12:52073902:GGTAA:Gdonor_loss0.9800
12:52073903:GTAAG:Gdonor_loss0.9800
12:52073904:T:TCdonor_loss0.9800
12:52070033:G:GAdonor_gain0.9700
12:52070046:C:Tdonor_gain0.9700
12:52070061:G:GAdonor_gain0.9700
12:52070069:G:Tdonor_gain0.9700
12:52070436:GGCA:Gdonor_gain0.9700
12:52072497:C:Gdonor_gain0.9700
12:52073902:GGT:Gdonor_gain0.9700
12:52070240:G:GTdonor_gain0.9600
12:52070455:G:GTdonor_gain0.9600
12:52070479:TCAAG:Tdonor_loss0.9600

AlphaMissense

1421 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:52073744:C:AR32S1.000
12:52076838:T:CF102S1.000
12:52076861:T:AW110R1.000
12:52076861:T:CW110R1.000
12:52076888:T:AW119R1.000
12:52076888:T:CW119R1.000
12:52076890:G:CW119C1.000
12:52076890:G:TW119C1.000
12:52076897:T:AW122R1.000
12:52076897:T:CW122R1.000
12:52077066:T:CF178S1.000
12:52077168:T:AI212N1.000
12:52073745:G:CR32P0.999
12:52073747:A:CS33R0.999
12:52073749:C:AS33R0.999
12:52073749:C:GS33R0.999
12:52073753:G:CG35R0.999
12:52073754:G:AG35D0.999
12:52073759:T:CF37L0.999
12:52073760:T:CF37S0.999
12:52073761:C:AF37L0.999
12:52073761:C:GF37L0.999
12:52073783:T:GY45D0.999
12:52076837:T:CF102L0.999
12:52076839:C:AF102L0.999
12:52076839:C:GF102L0.999
12:52076863:G:CW110C0.999
12:52076863:G:TW110C0.999
12:52076889:G:CW119S0.999
12:52076943:G:CR137P0.999

dbSNP variants (sampled 300 via entrez): RS1001053778 (12:52071738 C>T), RS1001149777 (12:52072006 C>T), RS1001155595 (12:52070202 C>T), RS1001268854 (12:52076061 T>C), RS1001379833 (12:52066747 A>G), RS1001379922 (12:52063332 C>A,T), RS1001704666 (12:52068948 G>A), RS1001762535 (12:52075841 A>C,G), RS1001828856 (12:52074716 T>C,G), RS1001837236 (12:52067821 C>T), RS1002091441 (12:52074374 G>T), RS1002707833 (12:52070042 G>C), RS1002788265 (12:52069470 G>A,C), RS1002808292 (12:52063889 GAAAA>G,GAAA,GAAAAA), RS1003035710 (12:52074435 C>T)

Disease associations

OMIM: gene MIM:615089 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

4 associations (top):

StudyTraitp-value
GCST004602_156Mean corpuscular volume4.000000e-11
GCST004630_182Mean corpuscular hemoglobin4.000000e-12
GCST009391_271Metabolite levels6.000000e-06
GCST90002392_382Mean corpuscular volume4.000000e-22

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004527mean corpuscular hemoglobin
EFO:0010428triacylglycerol 56:10 measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

33 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases expression, decreases reaction3
Valproic Acidaffects expression, increases expression3
Tobacco Smoke Pollutionincreases expression2
aristolochic acid Iincreases expression1
bisphenol Aaffects expression1
trichostatin Aaffects expression1
fisetindecreases expression, decreases reaction1
di-n-butylphosphoric acidaffects expression1
amyloid beta-protein (1-42)decreases expression, decreases reaction1
perfluorooctane sulfonic acidincreases expression1
trovafloxacinincreases expression1
abrineincreases expression1
PCI 5002affects cotreatment, increases expression1
Sunitinibincreases expression1
Acetaminophenincreases expression1
Air Pollutantsincreases expression, increases abundance1
Arsenicaffects methylation1
Chlorogenic Aciddecreases expression, decreases reaction1
Copperaffects binding, decreases expression1
Diazinonincreases methylation1
Dieldrinincreases response to substance1
Disulfiramaffects binding, decreases expression1
Drugs, Chinese Herbalincreases expression1
Smokedecreases expression1
Dihydrotestosteroneincreases expression1
Dronabinoldecreases expression1
Thiramincreases expression1
Zincaffects cotreatment, increases expression1
Cyclosporineincreases expression1
Aflatoxin B1decreases methylation1

Cellosaurus cell lines

3 cell lines: 3 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B1KCAbcam HeLa ATG101 KOCancer cell lineFemale
CVCL_SG01HAP1 ATG101 (-) 1Cancer cell lineMale
CVCL_SG02HAP1 ATG101 (-) 2Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.